Literature DB >> 20047913

High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.

Gisele Peirano1, David Richardson, Jana Nigrin, Allison McGeer, Vivian Loo, Baldwin Toye, Michelle Alfa, Colette Pienaar, Pamela Kibsey, Johann D D Pitout.   

Abstract

Phenotypic and genotypic methods were used to characterize extended-spectrum-beta-lactamase (ESBL)-producing Escherichia coli isolated in 2007 from 11 different Canadian medical centers. Of the 209 ESBL-producing E. coli isolates tested, 148 (71%) produced CTX-M-15, 17 (8%) produced CTX-M-14, 5 (2%) produced CTX-M-3, and 1 produced CTX-M-27. Overall, 96 (46%) of the ESBL producers belonged to clonal complex ST131, with the highest prevalence in Brampton, Calgary, and Winnipeg. ST131 is an important cause of community onset urinary tract infections due to ESBL-producing E. coli across Canada.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20047913      PMCID： PMC2825972          DOI： 10.1128/AAC.01338-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  25 in total

1.  Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1.

Authors:  A Karim; L Poirel; S Nagarajan; P Nordmann
Journal:  FEMS Microbiol Lett       Date:  2001-07-24       Impact factor: 2.742

2.  Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard.

Authors:  Susan B Hunter; Paul Vauterin; Mary Ann Lambert-Fair; M Susan Van Duyne; Kristy Kubota; Lewis Graves; Donna Wrigley; Timothy Barrett; Efrain Ribot
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

Review 3.  Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.

Authors:  Johann D D Pitout; Patrice Nordmann; Kevin B Laupland; Laurent Poirel
Journal:  J Antimicrob Chemother       Date:  2005-05-25       Impact factor: 5.790

4.  qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States.

Authors:  A Robicsek; J Strahilevitz; D F Sahm; G A Jacoby; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

5.  Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.

Authors:  Chi Hye Park; Ari Robicsek; George A Jacoby; Daniel Sahm; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

Review 6.  The CTX-M beta-lactamase pandemic.

Authors:  Rafael Cantón; Teresa M Coque
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

7.  Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type beta-lactamases in Enterobacteriaceae.

Authors:  J D D Pitout; N Hamilton; D L Church; P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2007-03       Impact factor: 8.067

Review 8.  The spread of CTX-M-type extended-spectrum beta-lactamases.

Authors:  G M Rossolini; M M D'Andrea; C Mugnaioli
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

9.  Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway.

Authors:  Umaer Naseer; Bjørg Haldorsen; Ståle Tofteland; Kristin Hegstad; Flemming Scheutz; Gunnar Skov Simonsen; Arnfinn Sundsfjord
Journal:  APMIS       Date:  2009-07       Impact factor: 3.205

10.  Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates.

Authors:  Johann D D Pitout; Deirdre L Church; Daniel B Gregson; Barbara L Chow; Melissa McCracken; Michael R Mulvey; Kevin B Laupland
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191
View more
  42 in total

1.  Emerging antimicrobial resistance among Escherichia coli strains in bloodstream infections in Toronto, 2006-2016: a retrospective cohort study.

Authors:  Sophie Mineau; Robert Kozak; Melissa Kissoon; Aimee Paterson; Anthony Oppedisano; Firas Douri; Kate Gogan; Barbara M Willey; Allison McGeer; Susan M Poutanen
Journal:  CMAJ Open       Date:  2018-12-03

2.  Multiple broad-spectrum Beta-lactamase targets for comprehensive surveillance.

Authors:  Kathy A Mangold; Barbara L Voss; Kamaljit Singh; Richard B Thomson; Donna M Schora; Lance R Peterson; Karen L Kaul
Journal:  J Clin Microbiol       Date:  2013-08-07       Impact factor: 5.948

3.  Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.

Authors:  Gisele Peirano; Akke K van der Bij; Joshua L Freeman; Laurent Poirel; Patrice Nordmann; Michael Costello; Veronika L Tchesnokova; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

4.  Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage.

Authors:  Gisele Peirano; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 5.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

6.  Genomic and Functional Analysis of Emerging Virulent and Multidrug-Resistant Escherichia coli Lineage Sequence Type 648.

Authors:  Katharina Schaufler; Torsten Semmler; Jukka Corander; Sebastian Guenther; Lothar H Wieler; Darren J Trott; Johann Pitout; Gisele Peirano; Jonas Bonnedahl; Monika Dolejska; Ivan Literak; Stephan Fuchs; Niyaz Ahmed; Mirjam Grobbel; Carmen Torres; Alan McNally; Derek Pickard; Christa Ewers; Nicholas J Croucher
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

7.  Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population.

Authors:  Lakshmi Chandramohan; Paula A Revell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

Review 8.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

9.  High rates of intestinal colonisation with fluoroquinolone-resistant ESBL-harbouring Enterobacteriaceae in hospitalised patients with antibiotic-associated diarrhoea.

Authors:  J Vervoort; M Gazin; M Kazma; T Kotlovsky; C Lammens; Y Carmeli; H Goossens; S Malhotra-Kumar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-04       Impact factor: 3.267

10.  Antibiotic-resistant Escherichia coli in women with acute cystitis in Canada.

Authors:  Warren J McIsaac; Rahim Moineddin; Christopher Meaney; Tony Mazzulli
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.